KYTHERA BIOPHARMACEUTICALS INC (KYTH) [Rocket]

In millions, except per share items	Jun-30-15	Mar-31-15	Dec-31-14	Sep-30-14	Jun-30-14	Mar-31-14	Dec-31-13	Sep-30-13
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Assets
Current assets:
Cash and cash equivalents	92.3	165.9	29.2	39.7	83.6	93.2	111.5	25.2
Marketable securities	92.5	45.8	70.4	77.7	51.1	58.2	55.5	28.9
Inventory	4.0
Prepaid expenses and other current assets	3.6	1.3	1.5	1.6	2.3	2.5	1.2	0.4
Total current assets	192.5	212.9	101.2	119.1	137.0	155.1	173.3	64.5
Property and equipment, net	2.1	1.9	1.8	1.9	0.8	0.1	0.1	0.1
Other assets	0.9	0.4	0.4	0.8	0.9	0.4	0.0	0.0
Total assets	195.4	215.3	103.4	121.7	138.8	155.6	173.4	64.6

Liabilities and stockholders' equity
Current liabilities:
Accounts payable	5.6	7.4	4.7	3.0	2.2	3.2	3.2	1.5
Accrued personnel costs	9.9	2.9	4.9	3.2	2.3	1.2	3.1	2.2
Accrued costs for services	9.9	3.1	4.9	3.2	2.3	2.9	3.2	5.7
Accrued interest	0.8	1.0	2.9	2.1	1.4	0.7	0.4	0.2
Notes payable, current portion		4.5	5.5	5.9	5.8	5.7	5.5	5.4
Other current liabilities	0.1	0.6	0.6	0.1
Total current liabilities	23.7	19.5	20.6	17.4	14.0	13.7	17.6	20.2
Notes payable-net of current portion	24.6	24.4	22.7	23.5	24.8	26.2	6.0	7.4
Other liabilities	0.6	0.7	0.7	0.6	0.4	0.0	0.0
Total liabilities	49.0	44.6	44.0	41.5	39.3	39.8	23.6	27.6

Commitments and contingencies
Stockholders' equity:
Additional paid in capital	520.4	507.3	367.3	363.9	360.6	357.5	322.1	195.2
Accumulated other comprehensive (loss) income	-0.1	0.0	-0.1	0.0	0.0	0.0	0.0	0.0
Accumulated deficit	-373.8	-336.7	-307.8	-283.6	-261.1	-241.7	-172.2	-158.2
Total stockholders' equity	146.5	170.7	59.4	80.3	99.5	115.8	149.8	37.0
Total liabilities and stockholders' equity	195.4	215.3	103.4	121.7	138.8	155.6	173.4	64.6